Clinical Trial Update: Evolution of Adipokines and Body Composition in Rheumatoid Arthritis Patients Receiving Tocilizumab Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating adipokines and body composition in rheumatoid arthritis patients treated with tocilizumab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Arthritis, Rheumatoid | Phase 4 | Status: COMPLETED